Timing of Umbilical Cord Clamping in Term Cesarean Deliveries

Sponsor
Acibadem University (Other)
Overall Status
Completed
CT.gov ID
NCT04812223
Collaborator
(none)
204
1
3
4.1
49.3

Study Details

Study Description

Brief Summary

The aim of this study is to show that delayed umbilical cord clamping or milking of the umbilical cord in pregnant women undergoing elective cesarean delivery might have better effects than early clamping, on neonatal results without causing maternal hemorrhage or negatively affecting the neonatal outcome , and to compare the superiority of these three methods to each other.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Delayed umbilical cord clamping
  • Procedure: Early umbilical cord clamping
  • Procedure: Milking of the umbilical cord
N/A

Detailed Description

Late clamping of the umbilical cord has been shown to have positive effects such as higher neonatal hemoglobin level, higher iron stores in the newborn around three to six months, and better neurological development. In 2017, American College of Obstetricians and Gynecologists (ACOG) recommended a minimum 30-60 seconds delayed clamping of the cord after a minimum of 30-60 seconds, regardless of the delivery method, in both term and preterm newborns. In addition, optimal placental transfusion can be achieved due to strong uterine tonus in vaginal delivery. However, this is not possible due to decreased uterine tonus and time constraint in cesarean delivery. The main concern in delayed clamping and milking of the umbilical cord is the possibility of maternal anemia due to excessive maternal blood loss in the short term, the need for maternal blood transfusion or maternal intensive care support, and the possibility of conditions such as hyperbilirubinemia, symptomatic polycythemia, and long hospital stay that may cause the need for phototherapy in the newborn. Although there are many studies in the literature regarding the neonatal results of the clamping timing of the umbilical cord, there are a limited number of articles regarding the results in patients who underwent term elective cesarean section. The aim of this study is to show that delayed umbilical cord clamping or milking of the umbilical cord in pregnant women undergoing elective cesarean delivery might have better effects than early clamping, on neonatal results without causing maternal hemorrhage or negatively affecting the neonatal outcome , and to compare the superiority of these three methods to each other.

Study Design

Study Type:
Interventional
Actual Enrollment :
204 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Prospective randomizedProspective randomized
Masking:
None (Open Label)
Primary Purpose:
Supportive Care
Official Title:
Prospective Randomized Comparison of the Results of Early Clamping, Delayed Clamping and Milking of the Umbilical Cord in Term Cesarean Deliveries
Actual Study Start Date :
Mar 25, 2021
Actual Primary Completion Date :
Jul 25, 2021
Actual Study Completion Date :
Jul 29, 2021

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Delayed Clamping

In this group, the umbilical cord will be clamped 60 seconds after the baby is born.

Procedure: Delayed umbilical cord clamping
The umbilical cord will be clamped 60 seconds after the baby is born.

Active Comparator: Early Clamping

In this group, the umbilical cord will be clamped 15 seconds after the baby is born.

Procedure: Early umbilical cord clamping
The umbilical cord will be clamped 15 seconds after the baby is born.

Active Comparator: Milking Clamping

In this group in which the umbilical cord will be milked, the cord will be milked 5 times with 2 seconds milking, then letting 2 seconds for spontaneous blood flow.

Procedure: Milking of the umbilical cord
The cord will be milked 5 times with 2 seconds milking, then letting 2 seconds for spontaneous blood flow.

Outcome Measures

Primary Outcome Measures

  1. Postpartum maternal hemorrhage [On postoperative day 0 and day 2]

    Preoperative and postoperative hemoglobin values will be recorded.

Secondary Outcome Measures

  1. Postpartum maternal anemia [İn postpartum 48 hours]

    Blood loss during surgery, need for blood transfusion after surgery will be recorded.

  2. Neonatal outcomes [Postpartum day 0]

    Weight of the baby

  3. Postpartum complaints [İn postpartum 48 hours]

    Postpartum nausea, vomiting, headache, dyspnea will be recorded

  4. Neonatal anemia [On postpartum day 2]

    Hematocrit levels of the newborn will be measured

  5. Neonatal jaundice [On postpartum day 2]

    Bilirubin levels of the newborn will be measured.

  6. Neonatal intensive care unit admission [In postpartum 5 days]

    Neonatal intensive care unit admissions in postpartum 5 days will be recorded.

  7. Maternal outcomes [On postpartum day 2]

    Postpartum maternal blood pressure, pulse will be recorded

  8. Newborn phototherapy need [In postpartum 2 weeks]

    Need of newborn phototherapy in postpartum 2 weeks will be recorded.

  9. Newborn positive pressure ventilation [Postpartum 5 days]

    Need of newborn positive pressure ventilation in postpartum 5 days will be recorded.

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 50 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • 37 weeks uncomplicated singleton pregnancy

  • Elective cesarean delivery

  • Cesarean section under regional anesthesia

Exclusion Criteria:
  • < 37 weeks pregnancy

  • Surgery performed under general anesthesia

  • Emergent cesarean

  • Multiple pregnancy

  • Medically unstable mother or fetus

  • Uncontrolled maternal diabetes

  • Major congenital malformation of chromosomal abnormality of the fetus

  • Intrauterine growth retardation

  • Prenatal asphyxia suspicion

  • True knot in the umbilical cord

  • İn case of meconium aspiration syndrome suspicion

Contacts and Locations

Locations

Site City State Country Postal Code
1 Acibadem Maslak Hospital Istanbul Sariyer Turkey 34457

Sponsors and Collaborators

  • Acibadem University

Investigators

  • Study Director: Mete Gungor, MD, Prof., Acıbadem Mehmet Ali Aydınlar University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Esra Ozbasli, Assistant Professor, Acibadem University
ClinicalTrials.gov Identifier:
NCT04812223
Other Study ID Numbers:
  • ATADEK 2021-01/44
First Posted:
Mar 23, 2021
Last Update Posted:
Aug 3, 2021
Last Verified:
Jul 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Esra Ozbasli, Assistant Professor, Acibadem University

Study Results

No Results Posted as of Aug 3, 2021